Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 12, 2018Randomized controlled trial demonstrates effectiveness of long-term treatment with sub-perception spinal cord stimulation
Boston Scientific Corporation (NYSE: BSX) today announced positive results from the WHISPER randomized controlled trial (RCT). The data, presented at the 2018 Annual Meeting of the North American...
-
Jan 11, 2018System offers non-opioid treatment option with multiple therapies for people with chronic pain
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Spectra WaveWriter™ Spinal Cord Stimulator (SCS) System. It is the...
-
Jan 9, 2018
Boston Scientific Corporation (NYSE: BSX) generated sales, based upon preliminary unaudited financial information, of approximately $2.41 billion during the fourth quarter ended December 31, 2017....
-
Dec 22, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 36th annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018 in San Francisco, CA. Mike Mahoney, chairman...
-
Dec 21, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 4, 2018 in Boston, MA. Mike Mahoney, chairman...